Biogen Claims Lead Among Adalimumab Biosimilars In Europe

 
• By Aidan Fry
  
Winner
Biogen claims it is the leading biosimilar adalimumab player in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products